Humira, also known as adalimumab, is a widely used biologic medication that is primarily prescribed for the treatment of various autoimmune conditions such as rheumatoid arthritis, psoriasis, and Crohn's disease. Biosimilars are biologic drugs that are highly similar to the reference product, in this case, Humira. They are developed to have comparable efficacy, safety, and quality to the original biologic.

While I was unable to access the specific information from the provided sources, I can provide you with a general overview of some of the biosimilars to Humira that have been approved or are in development.

1. Amjevita (adalimumab-atto): Approved by the U.S. Food and Drug Administration (FDA) in 2016, Amjevita is the first biosimilar to Humira to receive regulatory approval in the United States.

2. Cyltezo (adalimumab-adbm): Approved by the FDA in 2017, Cyltezo is another biosimilar to Humira that is indicated for the treatment of multiple autoimmune conditions.

3. Hyrimoz (adalimumab-adaz): Approved by the FDA in 2018, Hyrimoz is a biosimilar to Humira that is indicated for the treatment of multiple autoimmune conditions.

4. Hadlima (adalimumab-bwwd): Approved by the FDA in 2019, Hadlima is another biosimilar to Humira that is indicated for the treatment of multiple autoimmune conditions.

5. Abrilada (adalimumab-afzb): Approved by the FDA in 2019, Abrilada is a biosimilar to Humira that is indicated for the treatment of multiple autoimmune conditions.

It is important to note that the availability of biosimilars may vary by country and region. Additionally, the development and approval of biosimilars are ongoing processes, and new biosimilars to Humira may become available in the future.

Sources:
[1] Drug Patent Watch - Humira: https://www.drugpatentwatch.com/p/biologics/tradename/HUMIRA
[2] GoodRx - Humira Biosimilars: https://www.goodrx.com/humira/biosimilars
[3] Cardinal Health - Humira Biosimilar Landscape Overview: https://www.cardinalhealth.com/en/product-solutions/pharmaceutical-products/biosimilars/humira-biosimilar-landscape-overview.html